Operating Lease, Right-of-Use Asset in USD of HTG MOLECULAR DIAGNOSTICS, INC from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
HTG MOLECULAR DIAGNOSTICS, INC quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q1 2023.
  • HTG MOLECULAR DIAGNOSTICS, INC Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2023 was $893K, a 28.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

HTG MOLECULAR DIAGNOSTICS, INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2023 $893K -$352K -28.3% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $1.01M -$338K -25.1% 31 Dec 2022 10-Q 11 May 2023
Q3 2022 $1.04M -$404K -28% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $1.14M +$897K +364% 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 $1.25M +$896K +257% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $1.35M +$336K +33.3% 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 $1.44M +$698K +93.6% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $246K -$659K -72.8% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $349K -$690K -66.4% 31 Mar 2021 10-Q 13 May 2021
Q4 2020 $1.01M -$200K -16.5% 31 Dec 2020 10-K 29 Mar 2022
Q3 2020 $746K -$624K -45.5% 30 Sep 2020 10-Q 10 Nov 2020
Q2 2020 $905K -$489K -35.1% 30 Jun 2020 10-Q 11 Aug 2020
Q1 2020 $1.04M +$418K +67.2% 31 Mar 2020 10-Q 13 May 2020
Q4 2019 $1.21M 31 Dec 2019 10-K 25 Mar 2021
Q3 2019 $1.37M 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $1.39M 30 Jun 2019 10-Q 06 Aug 2019
Q1 2019 $621K 31 Mar 2019 10-Q 09 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.